Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience

por Ram, Ron, Scheid, Christof, Amit, Odelia, Chemnitz, Jens Markus, Moshe, Yakir, Hallek, Michael, Wolf, Dominik, Avivi, Irit, Holtick, Udo
Publicado 2019

P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS

por Gat, Roi, Neeman, Miri, Levi, Shai, Levi, Mor, Eilati, Nili, Bronstein, Yotam, Shragai, Tamir, Neuman, Tsipora, Segman, Yafit, Vitkon, Roy, Mittelman, Moshe, Avivi, Irit, Moshe, Yakir
Publicado 2023

P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL-WORLD SINGLE CENTER STUDY.

por Moshe, Yakir, Levi, Shai, Neeman, Miri, Gat, Roi, Levi, Mor, Eilati, Nili, Shragai, Tamir, Basood, May, Segman, Yafit, Baron, Yaeli, Luttwak, Efrat, Neuman, Tsipora, Vitkon, Roy, Mittelman, Moshe, Avivi, Irit
Publicado 2023

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy

por Barki-Harrington, Liza, Baron-Epel, Orna, Shaulov, Adir, Akria, Luiza, Barshay, Yossef, Dally, Najib, Deshet, Dana, Inbar, Tsofia, Koren-Michowitz, Maya, Leiba, Merav, Moshe, Yakir, Shvidel, Lev, Tadmor, Tamar, Yagenah, Shai, Zektser, Miri, Preis, Meir, Hellman, Ilana, Yahalom, Vered, Aviv, Ariel
Publicado 2021